Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19-Reference-Cited by-同舟云学术

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19

Published:2023-12-13 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Biernacki Karol¹,Ciupak Olga¹,Daśko Mateusz²,Rachon Janusz¹,Flis Damian³,Budka Justyna³,Inkielewicz-Stępniak Iwona³,Czaja Anna⁴,Rak Janusz⁴,Demkowicz Sebastian¹

Affiliation:

1. Department of Organic Chemistry, Gdańsk University of Technology, Gdańsk, Poland

2. Department of Inorganic Chemistry, Gdańsk University of Technology, Gdańsk, Poland

3. Department of Pharmaceutical Pathophysiology, Medical University of Gdansk, Gdańsk, Poland

4. Department of Physical Chemistry, University of Gdańsk, Gdańsk, Poland

Funder

Gdańsk University of Technology for: ‘Excellence Initiative - Research University’ (IDUB) program

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2290910

Reference23 articles.

1. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds

2. Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

3. Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development

4. Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by molecular dynamics simulations;Parmar M;Struct Chem,2022

5. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication;Antiviral Research;2024-08

2. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma;Pharmaceutics;2024-02-16